RNA-Protein Interaction Protein (RNA-PIP1) Regulates Cellular Processes

Target Name: RNPEPL1

NCBI ID: G57140

RNPEPL1

RNA-Protein Interaction Protein (RNA-PIP1) Regulates Cellular Processes

The research network protein (RNA-protein interactions) is a crucial protein that plays a significant role in the regulation of gene expression. One of the well-known proteins involved in the research network is the RNA-protein interaction protein, RNA-protein interaction protein 1 (RNA-protein interaction protein 1, RNA-PIP1), also known as RNPL1 (RNA-protein interaction protein 1). RNPL1 is a key regulator of the RNA-protein interactions, which are the interactions between RNA and proteins, and it is involved in various cellular processes such as cell growth, differentiation, and apoptosis.

RNA-protein interactions are the process by which proteins interact with RNA molecules to regulate gene expression. These interactions can be either positive or negative, leading to the formation of RNA-protein complexes or the disruption of these interactions. RNA-protein interactions are critical for the regulation of gene expression because they can alter the stability and activity of RNA molecules, leading to the translation of specific genes into proteins.

RNPL1 is a key regulator of RNA-protein interactions

RNPL1 is a protein that is involved in the regulation of RNA-protein interactions. It is a member of the research network protein family and is responsible for the regulation of the interactions between RNA and proteins. RNPL1 is essential for the regulation of cellular processes such as cell growth, differentiation, and apoptosis.

RNPL1 functions as a negative regulator of the nuclear export pathway

RNPL1 is involved in the regulation of the nuclear export pathway, which is the process by which proteins are exported from the nucleus to the cytoplasm. The nuclear export pathway is regulated by various proteins, including RNA-protein interaction proteins, which can either promote or inhibit the export of proteins.

RNPL1 is involved in the regulation of the nuclear export pathway by interacting with the protein p120GAP

P120GAP is a protein that is involved in the regulation of various cellular processes, including the nuclear export pathway. It is a GTPase enzyme that is involved in the regulation of protein stability and interactions. RNPL1 is known to interact with P120GAP and prevent its GTPase activity , which inhibits the export of proteins from the nucleus.

RNPL1 is involved in the regulation of the nuclear export pathway by interacting with the protein USP180

USP180 is a protein that is involved in the regulation of various cellular processes, including the nuclear export pathway. It is a nucleotide-binding protein that is involved in the regulation of protein stability and interactions. RNPL1 is known to interact with USP180 and prevent its nucleotide-binding activity, which inhibits the export of proteins from the nucleus.

RNPL1 is involved in the regulation of the DNA replication pathway

RNA-protein interactions can also play a role in the regulation of DNA replication. DNA replication is a critical process for the regulation of gene expression and is regulated by various proteins, including RNA-protein interaction proteins. RNPL1 is involved in the regulation of DNA replication by interacting with the protein DFIP1

Conclusion

In conclusion, RNPL1 is a protein that is involved in the regulation of various cellular processes, including the nuclear export pathway and DNA replication. It is a key regulator of the RNA-protein interactions and is involved in the regulation of cell growth, differentiation, and apoptosis. Therefore, RNPL1 is a potential drug target and a biomarker for various diseases.

Protein Name: Arginyl Aminopeptidase Like 1

Functions: Broad specificity aminopeptidase which preferentially hydrolyzes an N-terminal methionine, citrulline or glutamine

The "RNPEPL1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RNPEPL1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets